ArticleClinical ophthalmology (Auckland, N.Z.)2026
Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Treatment-Naïve Diabetic Macular Edema (BIOS-DME Study).
Somnath Chakraborty et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.